Ford T Monell MFT

Recommended Articles

• What is Postmenopausal Atrophic Vaginitis?

  Also known as vaginal atrophy, postmenopausal atrophic vaginitis is the thinning of vaginal walls resulting from low estrogen levels. Mostly, it develops after menopause.Menopause is when a woman is at the ages of between 45 and 55, a time when she cannot release eggs from her ovaries. Menstruation...

• How Google Glass Can Change How Kids with Autism Read and Speak

  Typically, children with autism struggle communicating with others in back and forth conversations. For this reason, researchers at the University of Toronto have developed an app called Holli, which works with Google Glass and serves as an aid for children with ASD.The software has a program that...

• A Cure for Crohn’s. How Hopeful Should We Be?

  In the United States alone, over 780,000 individuals are living with Crohn’s disease, a chronic inflammatory bowel disease that affects the entire digestive tract. To this day, it remains a painful, debilitating, and complex disease for which a cure has yet to be found. But now, research has...

• What Are Lymphocytes?

  A lymphocyte is a type of white blood cell (WBC) that has a significant function in the body's immune system. Lymphocytes function by properly responding to infectious microorganisms and other foreign invaders in the body. Lymphocytes can work alone, but some of them are also capable of...

• What Is Seborrheic Dermatitis?

  What is seborrheic dermatitis?Seborrheic dermatitis, or seborrhea, is a common skin disease that has no known direct cause. It is characterized by a red, itchy rash on the skin, often on the scalp, with scaly patches that flake off. It looks similar to eczema, psoriasis or an allergic reaction....

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...